Aqueous gel formulations containing 1-(2-methylpropyl)-1H-imidazo[4,5-c][1, 5]naphthyridin-4-amine

Details for Australian Patent Application No. 2006210587 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Ma, David Q.; Perman, Christopher S.; Hedenstrom, John C.; Skwierczynski, Raymond D.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006210587

PCT Pub. Number WO2006/084073

Priority 60/698,416 12.07.05 US; 60/649,932 04.02.05 US

Filing date 3 February 2006

Wipo publication date 10 August 2006

International Classifications

A61K 31/437 (2006.01)

C07D 471/12 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/084073 Priority application(s): WO2006/084073

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210589-ADAM-9 modulators

2006210572-Method for treating gefitinib resistant cancer